A Neurologist Answers Questions Patients Might Have about the New Alzheimer’s Drug Lecanemab
Editor’s Note (7/7/23): Scientific American published this interview with neurologist Samuel Gandy of the Icahn School of Medicine at Mount ...
Read moreDetails
